Effect of Mycobacterial Infection on Immune Status (EMIIS)
2026년 6월 4일 업데이트: Chao Cao, Ph.D., First Affiliated Hospital of Ningbo University
This study, titled "Effect of Mycobacterial Infection on Immune Status" (EMIIS), investigates the immune-driven mechanisms of mycobacterial infections, focusing on the dynamic immune characteristics of multidrug-resistant tuberculosis (MDR-TB), nontuberculous mycobacterial (NTM) infections, and tuberculous pleurisy.
Mycobacterial infections (including the Mycobacterium tuberculosis complex and nontuberculous mycobacteria) remain a major global public health threat.
EMIIS is a single-center, randomized, single-blind,prospective study.
The study recruited 120 participants, divided into groups of healthy individuals/community-acquired pneumonia patients, active pulmonary tuberculosis patients, latent tuberculosis infection patients, tuberculous pleurisy patients, and nontuberculous mycobacteria patients.
Blood samples were collected from all groups within 3 days before treatment and 2-3 months after treatment.
Pleural effusion samples were additionally collected from the tuberculous pleurisy group within 3 days before treatment and 2 months after treatment.
Exhaled breath condensate (EBC) was collected from the nontuberculous mycobacteria group.
Utilizing mass cytometry (CyTOF) and multi-dimensional indicators, the study aims to elucidate the immune-driven mechanisms of mycobacterial infections and provide new strategies for individualized treatment.
연구 개요
상태
모병
정황
연구 유형
관찰
등록 (추정된)
120
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
- 이름: Shiyi He
- 전화번호: +86-0574-87089878
- 이메일: shiyihii@163.com
연구 연락처 백업
- 이름: Chao Cao
- 전화번호: +86-0574-87089878
- 이메일: caodoctor@163.com
연구 장소
-
-
-
Ningbo, 중국
- 모병
- The First Affiliated Hospital of Ningbo University
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
아니
샘플링 방법
확률 샘플
연구 인구
Patients with clinical diagnosis including (active tuberculosis, latent tuberculosis, multidrug-resistant tuberculosis, tuberculous pleurisy, nontuberculous mycobacteria), older than 18 years, meeting the inclusion criteria and no exclusion criteria.
설명
Inclusion Criteria and Exclusion Criteria:
Inclusion Criteria：
- Age ≥ 18 years, all genders and races accepted.
- Patients with active pulmonary tuberculosis diagnosed clinically or by bronchoscopy within less than 1 week.
- Patients with latent tuberculosis infection (positive T-SPOT test but no evidence of active tuberculosis infection).
- Patients with tuberculous pleurisy with onset within less than 1 week.
- Voluntarily join this study and sign the informed consent form.
- Patients whose drug susceptibility test or NGS results indicate resistance to at least isoniazid and rifampicin (MDR-TB).
- Patients whose drug susceptibility test or NGS results indicate sensitivity to first-line anti-tuberculosis drugs.
- Patients whose drug susceptibility test or NGS results indicate resistance to only one anti-tuberculosis drug.
- Patients with newly identified nontuberculous mycobacterial infection (within less than 1 week) by sputum culture or NGS.
Exclusion Criteria：
- Immunosuppressive conditions including HIV infection, long-term use (>1 month) of immunosuppressive agents or corticosteroids, severe malnutrition, etc.
- Concurrent other lung diseases, severe liver or kidney dysfunction, severe endocrine diseases, hematological diseases, or malignant tumors that may affect the study outcomes.
- Patients with diabetes mellitus.
- Pregnant or lactating women.
- Patients unable or unwilling to provide informed consent, or with poor compliance.
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
|---|
|
Immunometabolic differences between DS-TB and MDR-TB
Using a prospective, single-center, observational study design, it is planned to enroll 30 patients divided into drug-susceptible tuberculosis and multidrug-resistant tuberculosis.
CyTOF technology was used to analyze the differences in immune subsets and metabolic functions.
|
|
To assess the effect of immune status on NTM
A total of 15 patients over the age of 18 diagnosed with non-tuberculous mycobacteria were included, and peripheral blood samples were collected after 2 months of treatment to analyze the changes in immune status and metabolic status of non-tuberculous mycobacterial patients in healthy people.
|
|
Significance of studying the immunometabolic status of tuberculous pleurisy
A total of 20 patients over the age of 18 diagnosed with tuberculous pleurisy were included in the plan, divided into high-symptom and low-symptomatic groups, and pleural fluid and peripheral blood samples were collected before and after treatment to analyze the changes in their immune status and metabolic status before and after treatment.
|
|
Study of immunometabolic status in different states of tuberculosis
A total of 15 patients over the age of 18 diagnosed with active pulmonary tuberculosis and 10 patients with latent pulmonary tuberculosis were enrolled, and peripheral blood samples were collected before and after treatment to analyze the changes in their immune status and metabolic status before and after treatment.
|
|
A study of exhaled air condensate in NTM patients versus CAP patients
A total of 30 patients over the age of 18 diagnosed with nontuberculous mycobacteria and 30 healthy or community pneumonia patients were enrolled, and their exhaled air condensate was collected before or within 2 weeks after treatment to analyze its composition.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
To establish a multi-immune pathway interaction network and composite biomarkers in mycobacterial infection thing
기간: 3 days before treatment and 2 months after treatment
|
This study utilized mass cytometry (CyTOF) and a pre-designed panel containing 41 metal-tagged antibodies for detection.
After data normalization and doublet exclusion, multiple machine learning algorithms were applied for clustering analysis to quantitatively compare the proportions of various immune subsets (such as Th1 cells, Th17 cells, classical monocytes, CD4TEM cells, CD8TEM cells,etc.)
among CD45+ leukocytes in the peripheral blood of healthy individuals and patients with active tuberculosis.
|
3 days before treatment and 2 months after treatment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Immune cell subsets and mechanisms of possible effects of anti-tuberculosis drugs
기간: 3 days before treatment and 2 months after treatment
|
This study utilized mass cytometry (CyTOF) and a pre-designed panel containing 41 metal-tagged antibodies for detection.
After data normalization and doublet exclusion, multiple machine learning algorithms were applied for clustering analysis to quantitatively compare the proportions of various immune subsets (such as Th1 cells, Th17 cells, classical monocytes, CD4TEM cells, CD8TEM cells,etc.)
among CD45+ leukocytes in the peripheral blood of healthy individuals and patients with active tuberculosis.
|
3 days before treatment and 2 months after treatment
|
|
Differences in immune subsets between normal persons and patients with active pulmonary tuberculosis
기간: 3 days before treatment and 2 months after treatment
|
This study utilized mass cytometry (CyTOF) and a pre-designed panel containing 41 metal-tagged antibodies for detection.
After data normalization and doublet exclusion, multiple machine learning algorithms were applied for clustering analysis to quantitatively compare the proportions of various immune subsets (such as Th1 cells, Th17 cells, classical monocytes, CD4TEM cells, CD8TEM cells,etc.)
among CD45+ leukocytes in the peripheral blood of healthy individuals and patients with active tuberculosis.
|
3 days before treatment and 2 months after treatment
|
|
To explore whether the peripheral blood before treatment contains a certain marker can predict the short-term efficacy
기간: 3 days before treatment and 2 months after treatment
|
This study utilized mass cytometry (CyTOF) and a pre-designed panel containing 41 metal-tagged antibodies for detection.
After data normalization and doublet exclusion, multiple machine learning algorithms were applied for clustering analysis to quantitatively compare the proportions of various immune subsets (such as Th1 cells, Th17 cells, classical monocytes, CD4TEM cells, CD8TEM cells,etc.)
among CD45+ leukocytes in the peripheral blood of healthy individuals and patients with active tuberculosis.
|
3 days before treatment and 2 months after treatment
|
|
Comparison of the dynamic changes of immune subsets in peripheral blood and pleural effusion of TP patients before and after treatment
기간: 3 days before treatment and 2 months after treatment
|
Using CyTOF with a 41-metal-labeled antibody panel, peripheral blood samples from healthy controls and untreated patients with tuberculous pleurisy were analyzed.
After data normalization and debarcoding, clustering was applied to determine the percentages of CD45+ leukocyte subsets (Th1, Th17, classical monocytes, CD4+/CD8+ effector memory T cells, and NK cells).
Patients were divided into high- and low-symptom groups based on symptom severity.
Immune subset proportions were compared between each patient group and healthy controls, as well as between the two patient groups.
|
3 days before treatment and 2 months after treatment
|
|
To explore the differences of peripheral blood immune subsets between TP patients and healthy people before treatment
기간: 3 days before treatment and 2 months after treatment
|
Using CyTOF with a 41-metal-labeled antibody panel, peripheral blood samples from healthy controls and untreated patients with tuberculous pleurisy were analyzed.
After data normalization and debarcoding, clustering was applied to determine the percentages of CD45+ leukocyte subsets (Th1, Th17, classical monocytes, CD4+/CD8+ effector memory T cells, and NK cells).
Patients were divided into high- and low-symptom groups based on symptom severity.
Immune subset proportions were compared between each patient group and healthy controls, as well as between the two patient groups.
|
3 days before treatment and 2 months after treatment
|
|
To explore the metabolic differences of three major nutrients between TP patients and healthy people before treatment
기간: 3 days before treatment and 2 months after treatment
|
Using CyTOF with an antibody panel including metabolic markers such as GLUT1 and CPT1A, the expression levels of these markers were measured in peripheral blood immune subsets (CD4+ T cells, CD8+ T cells, monocytes, etc.) from healthy controls and untreated patients with tuberculous pleurisy.
The median fluorescence intensity (MdFI) of GLUT1 and CPT1A on each subset was used as the primary metric to quantify differences in glucose metabolism and fatty acid oxidation capacity.
|
3 days before treatment and 2 months after treatment
|
|
Differences in metabolic function between multidrug-resistant tuberculosis group and drug-sensitive tuberculosis group
기간: 3 days before treatment and 2 months after treatment
|
In this study, CyTOF and a preconfigured panel consisting of 41 metal-conjugated antibodies were used for specimen detection.
After data normalization and doublet removal, multiple machine learning algorithms were utilized for cell clustering analysis.
We quantitatively compared the proportional differences of various immune subsets in peripheral blood CD45⁺ leukocytes among drug-resistant tuberculosis (DR-TB), drug-susceptible tuberculosis (DS-TB) and healthy control groups, including Th1 cells, Th17 cells, classical monocytes, CD4⁺ effector memory T cells and CD8⁺ effector memory T cells.
This study aims to characterize treatment-induced quantitative changes in immune subsets and provide evidence for screening novel biomarkers.
|
3 days before treatment and 2 months after treatment
|
|
Influence of immune status on the efficacy of NTM
기간: 3 days before treatment and 2 months after treatment
|
This study utilized mass cytometry (CyTOF) and a pre-designed panel containing 41 metal-tagged antibodies for detection.
After data normalization and doublet exclusion, multiple machine learning algorithms were applied for clustering analysis to quantitatively compare the proportions of various immune subsets (such as Th1 cells, Th17 cells, classical monocytes, CD4TEM cells, CD8TEM cells,etc.)
among CD45+ leukocytes in the peripheral blood of healthy individuals and patients with active tuberculosis.
|
3 days before treatment and 2 months after treatment
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2025년 7월 9일
기본 완료 (추정된)
2026년 7월 20일
연구 완료 (추정된)
2026년 7월 20일
연구 등록 날짜
최초 제출
2026년 5월 19일
QC 기준을 충족하는 최초 제출
2026년 6월 4일
처음 게시됨 (실제)
2026년 6월 10일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 6월 10일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 6월 4일
마지막으로 확인됨
2026년 6월 1일
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2025-157A-01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
아니요
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .